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Background. Selection by host immunity and antimalarial drugs has driven extensive adaptive evolution in Plas-
modium falciparum and continues to produce ever-changing landscapes of genetic variation.
Methods. We performed whole-genome sequencing of 69 P. falciparum isolates from Malawi and used popu-
lation genetics approaches to investigate genetic diversity and population structure and identify loci under selection.
Results. High genetic diversity (π = 2.4 × 10−4), moderately high multiplicity of infection (2.7), and low linkage
disequilibrium (500-bp) were observed in Chikhwawa District, Malawi, an area of high malaria transmission. Allele
frequency–based tests provided evidence of recent population growth in Malawi and detected potential targets of
host immunity and candidate vaccine antigens. Comparison of the sequence variation between isolates from Malawi
and those from 5 geographically dispersed countries (Kenya, Burkina Faso, Mali, Cambodia, and Thailand) detected
population genetic differences between Africa and Asia, within Southeast Asia, and within Africa. Haplotype-based
tests of selection to sequence data from all 6 populations identiﬁed signals of directional selection at known drug-
resistance loci, including pfcrt, pfdhps, pfmdr1, and pfgch1.
Conclusions. The sequence variations observed at drug-resistance loci reﬂect differences in each country’s his-
torical use of antimalarial drugs and may be useful in formulating local malaria treatment guidelines.
Keywords. Plasmodium falciparum; genomes; genetic epidemiology; Malawi.
An estimated 3.3 billion people worldwide are at risk of
malaria. The majority of cases (81%) and deaths (91%)
occur in sub-Saharan Africa, where children <5 years
old and pregnant women bear the greatest burden of
disease [1]. In Malawi, almost the entire population is
at risk of developing Plasmodium falciparum malaria,
which accounts for 40% of hospitalizations of childrenReceived 10 March 2014; accepted 12 June 2014; electronically published 19
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<5 years old, 34% of outpatient visits by children of all ages, and
40% of hospital deaths. Year-round malaria transmission occurs
in almost every part of the country and peaks during the annual
rainy season, from December to May [2]. Since 2005–2007, Ma-
lawi and its external donors have scaled up malaria control in-
terventions; coverage for long-lasting insecticide-treated bed
nets (LLINs) has reached 60%, intensive indoor residual spray-
ing (IRS) has been launched and expanded in districts with high
transmission rates, and artemisinin-based combination therapy
(ACT) has replaced sulfadoxine-pyrimethamine (SP) as the
ﬁrst-line treatment for malaria [1, 3]. However, childhood
cases of malaria have not declined since 2001 [3], and the overall
prevalence of anemia and parasitemia have not reﬂected the
scaled up access to malaria interventions. Recently, the preva-
lence of parasitemia in rural children was higher than that in
urban children (47% vs 15%), and the prevalence in the central
region of Malawi (50%) was higher than that in the southern
(42%) and northern (23%) regions (Malawi National Malaria
Indicator Survey, 2010, http://ﬁles.givewell.org/ﬁles/DWDA%
202009/AMF/Malawi_MIS_2010_Final.pdf ). On the other
hand, scaled up malaria interventions (eg, LLIN use) have ben-
eﬁtted pregnant women by reducing the prevalence of periph-
eral parasitemia (from 23.5% to 5.0%) and placental malaria
(from 25.2% to 6.8%) [4].
An integrated approach to malaria control is essential, and
the application of genomics is one area that can provide biolog-
ical insights into important evolutionary forces in P. falciparum.
An improved understanding of the parasite’s genetic diversity,
population structure, and natural selection will have practical
implications for developing methods of disease control. In par-
ticular, genetic variation enables the parasite to overcome host
immunity, antimalarial drugs, and vaccines to establish persis-
tent infections and increase transmission [5–7]. In this study, we
analyzed whole-genome sequence variation in 69 P. falciparum
isolates obtained from children in the Chikhwawa district of
Malawi to investigate the genomic epidemiology of P. falcipa-
rum in this area and to explore the impact of host immunity
and antimalarial drugs on the parasite population. We have
used allele frequency–based approaches to infer the parasite’s
demographic history in Malawi and discover genetic loci likely
to be under balancing selection [8]. Results from our analysis of
genetic diversity, linkage disequilibrium (LD), and multiplicity
of infection (MOI) are consistent with the high level of malaria
transmission in Chikhwawa District. Comparison of sequence
variation in parasite populations from Malawi and Kenya,
Burkina Faso, Mali, Cambodia, and Thailand, using haplo-
type-based tests and population differentiation metrics (FST),
identiﬁed signals of directional selection at known drug-
resistance loci, including pfcrt, pfdhps, pfmdr1, and pfgch1.
These ﬁndings highlight potential roles of genomics in guiding
malaria control efforts, such as monitoring of key drug bio-
markers and informing drug policy, and changes in parasite
populations structure that correspond to and can predict chang-
es in malaria epidemiology.
METHODS
Study Site and Patients
The study was performed in southern Malawi’s Chikhwawa
District (16°1′ S, 34°47′ E), a rural area of intense perennial ma-
laria transmission (entomological inoculation rate, 183 infective
bites/person/year) [9]. It is approximately 70 m above sea level,
divided throughout its length by the Shire River, and prone to
ﬂooding during the wet season. It has a tropical climate with a
mean annual temperature of 26°C, a single wet season from De-
cember to May, and an annual rainfall level of approximately
770 mm [9]. With an annual average infection prevalence in
2–10-year-old children that exceeds 40% [10], Chikhwawa Dis-
trict has one of the highest malaria transmission rates and is 1 of
12 sites in Malawi chosen for intensive antimalarial interven-
tions: IRS, extensive LLIN coverage, and ACT. SP is used for in-
termittent preventive treatment in pregnancy (IPTp) [11].
Permission to conduct the study was granted by ethics com-
mittees of the College of Medicine, Malawi and the Liverpool
School of Tropical Medicine. Written informed consent was
obtained from a parent or guardian of each child.
Sample Collection and Processing
Between December 2010 and July 2011, 93 whole-blood sam-
ples were collected from children participating in a clinical
trial at Chikhwawa District Hospital. Blood was depleted of leu-
kocytes by CF11 column ﬁltration [12], and genomic DNA was
extracted using the QIAamp DNA Blood Midi Kit (Qiagen).
Human and P. falciparum DNA levels were quantiﬁed using Pi-
coGreen analysis and quantitative real-time polymerase chain
reaction (PCR), using the Applied Biosystems stepOne RT-
PCR system [13]. Samples used for sequencing yielded >50 ng
of DNA and had <80% human DNA contamination. Samples
were sequenced by the Illumina Genome Analyzer IIx or the Il-
lumina HiSeq 2000, using the manufacturer’s recommended
protocol [14], with a minimum of 76-bp paired-end reads.
Data Processing: Alignment, Single-Nucleotide Polymorphism
(SNP) Discovery, and Quality Filtering
Detailed description of the analysis pipeline has been described
elsewhere [15, 16]. Brieﬂy, short reads for all 93 samples were
mapped to the 3D7 reference genome (version 3.0), using
SMALT (http://www.sanger.ac.uk/resources/software/smalt)
with default parameters, and SNPs were called using SAMtools
(http://samtools.sourceforge.net). This process identiﬁed
115 965 SNPs across the 93 samples, 24 of which were discarded
because of very low coverage (average coverage across the whole
genome, <10-fold). For the remaining 69 samples (average
coverage across whole genome, >35-fold), we retained 88 655
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high-quality SNPs (76.4%) in their nuclear genomes that met
the following criteria: (1) biallelic; (2) quality scores of >30
(error rate, <1 per 1000-bp); (3) not in genomic positions at
the very extremes of the coverage distribution (sample average
coverage, <10-fold or >2000-fold), which could reﬂect deletions
or copy number variants, respectively [17]; (4) not located in
subtelomeric regions, the hypervariable var, riﬁn, and stevor
gene families, or regions of low uniqueness; and (5) no SNP po-
sitions with ≥3 problematic genotypes (missing or mixed).
Uniqueness was calculated by a sliding 54-bp window of contig-
uous sequence across the 3D7 reference genome and detecting
the presence of this motif elsewhere in the genome. Only SNPs
that were in unique positions were retained. Genotypes at SNP
positions were called using ratios of coverage. Heterozygous
calls were converted to the majority genotype if the coverage
ratio was 80:20 or greater [15, 18], and the resulting majority al-
lele data were used for further analysis. The ﬁltering of samples
and SNPs with mixed genotypes minimized any potential ef-
fects of multiplicity of infection. Progeny of the HB3 × DD2
cross (n = 25; 35 832 SNPs [19]) and other population data
(Kenya, n = 37; Burkina Faso, n = 40; Mali, n = 40; Cambodia,
n = 80; Thailand, n = 80; 294 187 SNPs; [16]) were processed
in the same way. The 4 mitochondrial SNPs (mt772, mt1692,
mt4179, and mt4952) were extracted from the alignments and
the genotypes called as described above. Public accession num-
bers for sequence data are contained in SRA studies
(ERP000190 and ERP000199; http://www.malariagen.net).
Population Genetics
For the high-quality SNPs (n = 88 655) in the Malawian popula-
tion, we estimated the genetic diversity by calculating the average
pair-wise nucleotide diversity (π). We used DnaSP [20] software
to compute the allele frequency-based Tajima D test [8] and Fu
and Li’s D and F metrics [21] to identify genes under balancing
selection. Results from Fu and Li’s D and F metrics correlated
highly with those from the Tajima D test (Spearman ρ, 0.85)
and were not analyzed further. To detect signals of directional se-
lection, the integrated haplotype score (iHS) [22] was used, and
its P values were computed from standardized values based on a
2-tailed conversion from a Gaussian distribution [23]. The MOI
in Malawi was estimated using a novel method of counting the
unique haplotypes formed by polymorphism on paired sequenc-
ing reads [24]. We estimated recombination rate in this popula-
tion using 2 progeny crosses. First, rates from the 7G8 × GB4
(Ghana × Brazil origin) were accessed [25]. Second, rates from
the HB3 × DD2 (Honduras × Indo-China origin) cross [19]
were estimated using the R QTL library (http://www.rqtl.org).
For comparisons between populations (Malawi vs others,
n = 294 187 SNPs), we ﬁrst applied the principal component
analysis (PCA), based on a matrix of pair-wise identity by state
values, followed by the cross-population long-range LD method,
XP-EHH [26] and population differentiation metric FST [27].
P values for the XP-EHH estimates were calculated using a
Gaussian approximation. A signiﬁcance threshold of P < .0006
was established for both iHS and XP-EHH, using a simulation
approach. We used the ranked FST statistics to identify the infor-
mative polymorphism driving the clustering in the PCA. LD was
measured using the r2 metric [28], calculated for pairs of SNPs
with different physical separation up to 10-kb, using a sliding
window approach. The R statistical package was used to analyze
the results.
RESULTS AND DISCUSSION
Genetic Diversity and Signatures of Selection Within the
Malawian Population
We identiﬁed 88 655 high-quality biallelic SNPs (approximately
1 SNP per 260 bp, compared with approximately 1 per 266 bp
among isolates worldwide [18]) in robust genomic regions of the
69 samples with good sequence coverage. The overall π in Mala-
wian samples (0.00025; 95% conﬁdence interval, .00023–.00026)
is consistent with estimates of high genetic diversity observed in
African samples, especially in regions of high transmission [5, 23,
29].We observed high variability in π across chromosomes (min-
imum, 0.00011, chromosome 3; maximum, 0.00037, chromo-
some 4), probably because of variation in recombination rates.
Analysis of antigenic regions of extremely high diversity (200
genes; average π, 0.00050) led to a minor decrease in diversity
(average π, 0.00023; P = .035, by the Wilcoxon signed rank test
on differences). Regions with elevated diversity may encode an
antigenic or polymorphic locus that may be useful for vaccine
approaches. Modest positive correlations were observed between
recombination rate and diversity (Spearman ρ, r = 0.075 for
7G8 × GB4; r = 0.101 for HB3 ×DD2).
To examine the potential effects of recombination, we looked
at levels of LD in the Malawian population, which decayed rap-
idly within a few 100 bp and reached a baseline level within 500
bp. The decay in LD was more rapid in Malawian parasites than
in Asian parasites, as previously reported (MAF, 10%; Figure 1)
[16, 18]. The lower LD in Malawian samples suggests high levels
of outcrossing (and effective recombination), as expected in areas
of relatively high transmission intensity [23]. Indeed, a high EIR
(183 infective bites/person/year) has previously been described
for this Malawian population [9], consistent with a previous re-
port of high estimated MOI (median, 2.7; range, 1–10) [30], and
was higher than 2 Southeast Asian populations (medians, <1.5)
[24]. In this latter study, <10% of samples had multiple infections,
compared with approximately 50% of African samples, also re-
ﬂecting differing transmission patterns [24]. Further examination
of LD identiﬁed 40 genomic regions (containing at least 5 SNPs)
with high average r2 values (>0.5) that extended beyond 1 kb (Sup-
plementary Table 1). We found no evidence of low recombination
rates in these regions, and none of the genes were in the lowest
10th percentile of the recombination rates distribution for either
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genetic cross. One particular gene, piesp2 (PF3D7_0501200, which
encodes a parasite-infected erythrocyte surface protein), showed a
pattern of LD extending to 1 kb, suggesting that this region is
under recent positive selection.
Computation of iHS for the Malawian SNPs identiﬁed 14
chromosomal loci likely to be under positive directional selec-
tion (P < .0006; Table 1 and Figure 2). These include regions
surrounding 2 SP resistance loci (pfdhps and pfgch1) that ex-
tend to several genes, suggesting that drug selection has pro-
duced chromosomal segments of selective sweeps. We did not
detect selection signals at pfcrt, but there was evidence of
selection within 3 kb of the gene. This may be expected with
regression back to the pfcrt wild-type alleles after withdrawal
of chloroquine (CQ) from Malawi >15 years ago. Signals were
also detected within 10 kb of pfubp1, a homologue of a Plasmo-
dium chabaudi gene linked to artemisinin resistance. In Kenya,
pfubp1 alleles were recently found to be under directional selec-
tion and associated with reduced in vitro susceptibility to arte-
misinin [31]. Positive directional selection signals were also
evident in msp6 and msp3.8, pfama1, trap, and msp7 on chro-
mosomes 10, 11, 13, and 14, respectively. These genes are ex-
pressed predominantly in merozoites and are thought to be
Figure 1. Decay in linkage disequilibrium (LD) between populations. LD decays rapidly in Malawi, compared with Southeast Asian populations.
Table 1. Genetic Loci Under Recent Positive Directional Selection in Malawi, Identiﬁed Using the Integrated Haplotype Score at
A Signiﬁcance Threshold of P < .0006
Chromosome Start Stop Locus Characteristic(s)
1 178 726 180 317 Within approximately 10 kb of pfubp1
512 851 558 256 Contains 7 genes (PF3D7_0113700–PF3D7_0114500)
2 842 699 855 734 Contains 3 genes, including clag2
4 1 065 176 1 144 415 Contains 16 genes (PF3D7_0423600–PF3D7_0425400)
5 966 314 1 181 373 Approximately 4-kb from pfmdr1
7 409 122 470 642 Approximately 3-kb from pfcrt
507 357 665 385 Contains 27 genes (PF3D7_0711700–PF3D7_0714500)
1 358 889 1 380 385 Contains 4 genes, including eba175
8 449 188 585 854 Contains 28 genes, including pfdhps
10 1 389 354 1 434 268 Contains 12 genes, including msp3, 3.3, 3.8, 6, and 11
11 1 294 082 1 295 369 pfama1
12 800 894 1 059 078 Contains 58 genes, including pfgch1
13 102 848 106 661 trap
14 2 982 003 3 149 504 Contains 32 genes
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primarily under balancing selection, consistent with other obser-
vations in Asian and African populations [31–33]. These non–
drug-related drivers of directional selection, as well as antigenic
loci that modulate drug resistance (eg, msp3.8 and members of
the clag gene family [34, 35]), require further investigation. As ex-
pected, Malawian samples have the African-speciﬁc K189T
mutation in PF3D7_1343700 but none of the so-called K13-
propeller mutations (eg, C580Y, R539T, or Y493H) associated
with artemisinin resistance in Cambodia [36].
Interrogation of the allele frequency spectrum of differ-
ent classes of nucleotide sites showed an excess of rare alleles
(Supplementary Figure 1), with coding, nonsynonymous,
Figure 2. Positive directional selection in the Malawian Plasmodium falciparum population. Dashed line indicates genome-wide integrated haplotype
scores at a signiﬁcance threshold of P < .0006. Vertical lines indicate (from left) locations of pfdhfr, pfmdr1, pfcrt, and pfdhps, respectively.
Table 2. Genes Under Balancing Selection, Deﬁned as ≥5 Single-Nucleotide Polymorphisms and a Tajima D of≥ 1
Gene Tajima D Start Stop Protein Encoded by Gene
PF3D7_1036300 3.26 1 432 702 1 434 553 Merozoite surface protein 3.8
PF3D7_0710000 2.52 447 902 457 801 Conserved Plasmodium protein; unknown function
PF3D7_0425400 2.06 1 144 011 1 144 822 Plasmodium exported protein (PHISTa); unknown function
PF3D7_0221000 1.98 848 124 849 107 Plasmodium exported protein; unknown function
PF3D7_0709300 1.96 414 302 421 420 Cg2 protein
PF3D7_0710200 1.94 463 705 471 598 Conserved Plasmodium protein; unknown function
PF3D7_0424400 1.85 1 100 085 1 102 381 Surface-associated interspersed protein 4.2 (SURFIN 4.2)
PF3D7_0630800 1.83 1 288 574 1 290 718 Conserved Plasmodium protein; unknown function
PF3D7_1133400 1.72 1 293 957 1 295 622 Apical membrane antigen 1
PF3D7_1149600 1.59 2 001 079 2 003 312 DnaJ protein; putative
PF3D7_1126100 1.57 1 018 557 1 021 025 Autophagy-related protein 7; putative
PF3D7_0731500 1.56 1 358 502 1 362 925 Erythrocyte binding antigen-175
PF3D7_0104100 1.49 178 094 180 554 Conserved Plasmodium membrane protein; unknown function
PF3D7_0516300 1.39 679 096 680 745 Transfer RNA pseudouridine synthase; putative
PF3D7_1035400 1.37 1 404 453 1 405 160 Merozoite surface protein 3
PF3D7_0113800 1.24 527 113 536 327 Duffy binding-like–containing protein; unknown function
PF3D7_0630300 1.15 1 260 750 1 269 383 DNA polymerase epsilon, catalytic subunit a; putative
PF3D7_0103600 1.03 161 480 165 521 Adenosine triphosphate–dependent RNA helicase; putative
PF3D7_1035700 1.01 1 413 250 1 415 182 Duffy binding-like merozoite surface protein
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synonymous, and intergenic sites more skewed than expected
under neutrality. This observation indicates recent population
expansion, as has been demonstrated in other African popula-
tions [23, 37]. Use of the allele frequency-based Tajima D test
to evaluate each polymorphic gene across the genome identi-
ﬁed regions likely to be under balancing selection. There was a
strong positive correlation between π and Tajima D values
(Spearman ρ, 0.532), providing potential evidence of increasing
diversity with balancing selection. For the 2073 genes (51.1%)
with at least 5 SNPs computed for TajimaD, the majority of val-
ues (96.5%) were negative. To negate any confounding effects of
population expansion and difﬁculties in establishing signiﬁ-
cance levels, we report 19 genes with Tajima D values of >1
(Table 2). These include a signiﬁcant overrepresentation of
genes (msp3.8, msp3, dbl-msp, eba-175, ama1, and surﬁn4.2) in-
volved in merozoite invasion of erythrocytes and previously
Table 3. Genetic Loci Under Directional Selection in All 6 Populations Identiﬁed Using XP-EHH at a Signiﬁcance Threshold of P < .0006
Population, Chromosome Start End Locus Characteristic(s)
Malawi
1 180 314 193 846 Contains 3 genes, including pfubp1
487 895 489 460 Contains gene encoding glutamic acid–rich protein
4 755 433 881 703 Approximately 6 kb from pfdhfr
990 908 991 327 Contains gene encoding conserved Plasmodium protein; unknown function
5 1 042 259 1 109 432 Approximately 8 kb from pfmdr1
8 532 499 585 854 Contains 14 genes, including pfdhps
10 1 326 109 1 327 397 Contains gene encoding S-adenosylmethionine decarboxylase/ornithine
decarboxylase
12 461 137 473 836 Contains 5 genes (PF3D7_1210200–PF3D7_1210600)
946 416 954 490 Approximately 30 kb from pfgch1
983 440 1 016 281 Contains 9 genes (PF3D7_1224200–PF3D7_1225000)
1 004 000 1 022 661 Contains 5 genes (PF3D7_1224700–PF3D7_1225100)
13 1 465 713 1 465 965 Contains gene encoding sporozoite surface protein 2 (trap)
14 1 688 102 1 688 881 Contains gene encoding serine/threonine protein kinase; putative
2 135 779 2 137 007 Contains rhoptry neck protein 2 (ron2)
Kenya
6 1 116 365 1 222 963 Contains 20 genes (PF3D7_0627800–PF3D7_0629700)
7 376 423 417 661 pfcrt
8 467 328 468 623 Contains gene encoding asparagine-rich antigen Pfa55-14
Mali
6 1 205 649 1 290 486 Contains 16 genes (PF3D7_0629300–PF3D7_0630800)
7 376 423 470 941 pfcrt
505 661 614 698 Contains 13 genes (PF3D7_0711500–PF3D7_0713500)
1 100 440 1 326 844 Contains 48 genes (PF3D7_0726200–PF3D7_0731900)
8 468 447 469 357 Contains gene encoding asparagine-rich antigen Pfa55-14
Burkina Faso
1 487 895 489 267 Contains gene encoding glutamic acid–rich protein
7 432 780 507 284 Within 26 kb of pfcrt
908 940 918 733 Contains 3 genes (PF3D7_0721000–PF3D7_0721200)
8 416 971 422 505 Contains gene encoding plasmepsin X
Thailand
4 709 512 771 505 pfdhfr
7 339 092 451 640 pfcrt
8 468 447 586 054 pfdhps
703 454 712 742 Contains 5 genes (PF3D7_0814600–PF3D7_0815100)
Cambodia
6 1 109 423 1 135 810 Contains 5 genes (PF3D7_0627700–PF3D7_0628100)
7 332 719 453 986 pfcrt
875 300 931 176 Contains 17 genes (PF3D7_0720000–PF3D7_0721500)
8 468 669 479 732 Contains gene encoding asparagine-rich antigen Pfa55-14
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reported to be under immune selection [31, 37, 38]. The identi-
ﬁcation of additional genes potentially under immune selection
may suggest additional proteins as candidate vaccine antigens.
Comparison of the Malawian Population to Other Populations
Of the 294 187 high-quality SNPs identiﬁed across the 6 popu-
lations (Malawi, 46% of SNP sites observed; Kenya, 30%; Bur-
kina Faso, 33%; Mali, 37%; Cambodia, 22%; and Thailand,
23%), only 8% were polymorphic in Malawi. The comparison
of Malawian samples to samples from each of the 5 populations,
using the cross population long-range haplotype method (XP-
EHH), identiﬁed regions potentially under positive directional
selection at or near known drug-resistance loci (pfdhps, pfcrt,
and pfgch1; Table 3). Although low recombination rates may
confound the directional selection interpretation, a follow-up
analysis of genetic cross-progeny showed that these identiﬁed
regions do not have low recombination rates.
In Malawi, directional selection at pfdhps is probably due to
high SP pressure, while pfcrt selection in Burkina Faso, Mali,
Cambodia, and Thailand is likely due to high CQ pressure.
Figure 3. Principal components analysis using single-nucleotide polymorphisms differentiates Plasmodium falciparum isolates by continent and within
Southeast Asia (A) and between East and West Africa (B). The proportion of variation explained by the ﬁrst 2 principal components is 13.4% (A) and 3.8%
(B).
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Signals detected at pfcrt and pfdhps in Kenya and Thailand are
also indicative of CQ and SP selection, respectively. The lack of
evidence for selection at pfcrt in Malawi reﬂects the withdrawal
of CQ and subsequent increase in the ancestral CQ-susceptible
allele frequency, due to the re-expansion of a persistent minor-
ity population of CQ-susceptible parasites. This observation
suggests that parasites carrying ancestral pfcrt alleles have
greater ﬁtness in the absence of CQ pressure [39].
The observed selective sweep surrounding the GTP cyclohy-
drolase gene (pfgch1; PF3D7_1224000) on chromosome 12 is
unique to Malawi in this study. The pfgch1 gene is the ﬁrst
gene in the folate biosynthesis pathway, and adaptive selection
could have resulted from SP pressure [40]. A similar phenome-
non was previously observed in Thai parasites that evolved re-
duced microsatellite diversity and increased LD ﬂanking the
pfgch1 locus during SP selection [40]. Further work, such as
analysis of copy number variation, may provide better insights
into the selection processes at work at this locus, as positive se-
lection may result from rapid spread of chromosomes carrying
multiple copies of pfgch1 [40]. Selection signals in the trap gene
are thought to reﬂect genetic adaptation to divergent host
ligands [33] involved in the motility of sporozoites and their
invasion of hepatocytes and mosquito salivary glands [41].
The populations of P. falciparum are geographically struc-
tured, resulting from adaptation to different environments
and selection pressures [16, 18]. Prior to analyzing sequence
data for population structure, SNPs in the mitochondrial ge-
nome (mt; approximately 6 kb) were used to conﬁrm that the
Malawian samples were of African origin. Haplotypes were
formed using 4 established continent-speciﬁc polymorphisms
(mt772, mt1692, mt4179, and mt4952) [42]. Two haplotypes
of African origin were present: CGCC (identical to 3D7) and
CACC, in 90.8% and 9.2% of samples, respectively. High
read-depth coverage in mt (median and mean, approximately
1560-fold and 1245-fold, which were approximately 19-fold
and 23-fold greater, respectively, than the nuclear genome)
was consistent with the known multiple copies of the organelle
in a P. falciparum cell [43]. There was no obvious clustering of
Malawian SNPs (data not shown), probably because all samples
were obtained in the same season and district. A PCA of the
294 187 SNPs from all 6 populations revealed expected differ-
ences between Africa and Asia, within Southeast Asia, and
within Africa (Figure 3), as previously reported [16].We further
applied the SNP-wise FST metric to measure genomic diver-
gence across the 6 populations. At a stringent genome-wide cut-
off (FST ≥ 0.2; top 0.5% overall), we identiﬁed the most
divergent loci between Malawian samples and the other 5 pop-
ulations. The frequency of alleles encoding known drug targets
and their divergence between populations is shown in Supple-
mentary Table 2 and Table 4.
The interpopulation differences at drug resistance loci likely
reﬂect local historical parasite adaptation to drug pressure, lead-
ing to ﬁxation or near ﬁxation of the implicated resistance
alleles, as evidenced by the following observations. First, reduc-
tions in the prevalence of pfcrt-K76T alleles after CQ withdraw-
al differs between Malawi (0%) and Kenya (31%), a disparity
that has been observed previously [44, 45]. The return of CQ-
susceptible malaria to Malawi has prompted discussions of
the possibility that CQ, once rendered ineffective, may become
useful again [46]. Second, the prevalence of pfcrt-K76T alleles
differs between Mali (62%) and Burkina Faso (36%), where
CQ is still used. Third, pfcrt-K76T alleles have reached ﬁxation
in Cambodia and Thailand; indeed, CQ remains the ﬁrst-line
treatment for Plasmodium vivax malaria in these 2 countries
and thus may continue to select for the resistant genotype in
P. falciparum [47]. Fourth, pfdhps-K540E alleles have reached
Table 4. Frequency of Alleles Conferring Drug Resistance Across the 6 Populations
Locus, Mutation Malawi Kenya Mali Burkina Faso Thailand Cambodia
CRT
K76T 0 0.31 0.62 0.36 1 1
Q271E 0 0.23 0.59 0.23 1 0.99
N326S 0 0.05 0.01 0.05 1 0.91
I356T 0 0 0.18 0.09 1 0.92
DHPS
S436A 0 0.03 0.61 0.49 0.18 0.33
A437G 0 0.18 0.61 0.39 0 0.02
K540E 1 0.81 0 0 0.87 0.41
A581G 0 0 0 0 0.78 0.57
MDR
N86Y 0.02 0.55 0.26 0.27 0.01 0.02
N1226Y 0 0.01 0 0 0.58 0.01
D1246Y 0 0.43 0.02 0.07 0 0
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ﬁxation in Malawi, despite the drug policy change from SP to
ACT in 2007. The persistence of these alleles may be maintained
by the use of SP as the ﬁrst-line drug for IPTp and the use of
trimethoprim/sulfamethoxazole, an antifolate antibiotic used
widely for various indications. Although FST values may reﬂect
differences in allele frequency due to differential selective pres-
sure, they may also simply reﬂect random genetic drift. Further
analysis at the gene level provided evidence of a high correlation
between maximum FST and XP-EHH (Spearman ρ: overall,
0.181; in Kenya, 0.164; in Burkina Faso, 0.155; in Mali 0.143;
in Cambodia, 0.261; and in Thailand, 0.264), suggesting that
some signals of directional selection were detected using the
population differentiation approach. However, it is possible
that extreme XP-EHH could reﬂect demographic characteristics
rather than selection pressure.
Finally, a comparison of our data with those from a recent
analysis fromWest Africa (Gambia and Guinea) highlights sev-
eral key points about the P. falciparum population structure in
Africa [48]. First, the predominantly negative Tajima D values
in the African (Guinean and Malawian) populations indicate a
historical population expansion in Africa. Second, balancing se-
lection acts on a similar set of genes (including those predom-
inantly expressed in merozoites and involved in erythrocyte
invasion) in Guinean and Malawian samples, suggesting that
it acts on similar antigenic targets irrespective of differing
population demographic characteristics. For example, msp3.8
has the highest Tajima D value in both Malawi and Guinea.
Third, signatures of directional selection at drug resistance
loci appear to be population speciﬁc as expected, reﬂecting his-
torical differences in antimalarial drug use. For example, there
are strong signatures of directional selection around pfcrt in
Guinea (where CQ was used until 2006) but not in Malawi
(where CQ was withdrawn in 1998). In contrast, there is evi-
dence of strong selection in pfdhps in Malawi but only weak se-
lection in Guinea, where SP was never introduced as ﬁrst-line
treatment for malaria [48].
CONCLUSION
Our study demonstrates how the large and growing number of
P. falciparum whole-genome sequences can be used to under-
stand malaria biology and impact disease control. Estimates of
parasite genetic diversity, LD, and MOI will improve our under-
standing of various aspects of malaria epidemiology, including
infection dynamics, transmission levels, pathogenesis mecha-
nisms, and drug efﬁcacy. For example, the high nucleotide
diversity, short-range LD, and MOI found in Malawian samples
reﬂect the high transmission history of the district in which they
were collected. Additionally, we have provided insights into the
parasite population structure within Malawi and placed it in the
context of other populations, facilitating the recognition of po-
tentially imported cases into the country and targeting of
effective malaria control measures. Our whole-genome analyti-
cal approach has detected evolutionary genetic signatures and
genes under selective pressure due to drug resistance or viru-
lence. For example, we observed differences at drug resistance
loci between geographically distinct populations due to dif-
fering histories of antimalarial drug use. However, we also ob-
served evidence of selection pressure in genes with unknown
functions, which can be investigated in future experiments.
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